Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan-Reference-Cited by-同舟云学术

Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan

Published:2021-04 Issue:2 Volume:54 Page:228-237
ISSN:1684-1182
Container-title:Journal of Microbiology, Immunology and Infection
language:en
Short-container-title:Journal of Microbiology, Immunology and Infection

Author:

Lin Jia-Juen^ORCID,Lin Kuan-Yin,Tang Hung-Jen,Lin Shih-Ping,Lee Yi-Chien,Liu Chun-Eng,Huang Yu-Shan,Wang Ning-Chi,Li Chia-Wen,Ko Wen-Chien^ORCID,Yang Hao-Jan,Lee Yuan-Ti^ORCID,Hung Chien-Ching

Funder

Chung Shan Medical University Hospital

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine,Immunology and Allergy

Reference37 articles.

1. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS);Thio;Lancet,2002

2. Guidelines for the prevention care and treatment of persons with chronic hepatitis B infection: Mar-15;World Health Organization,2015

3. Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices;Schillie;MMWR Recomm Rep,2018

4. Global progress toward universal childhood hepatitis B vaccination, 2003;Gacic-Dobo;MMWR Morb Mortal Wkly Rep,2003

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia;HIV Medicine;2023-09-21

2. Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected Patients;Microbiology Spectrum;2023-06-15

3. Concurrent HCV or fatty liver in patients with chronic hepatitis B virus infection;Comprehensive Guide to Hepatitis Advances;2023

4. Virological responses to tenofovir-alafenamide-containing antiretroviral therapy in people living with HIV co-infected with lamivudine-resistant or lamivudine-susceptible hepatitis B virus;International Journal of Antimicrobial Agents;2022-11

5. Evolution of Hepatitis B Virus (HBV) Serologic Markers Among Antiretroviral-Naive Young People Living With Human Immunodeficiency Virus Who Had Undergone Neonatal HBV Vaccination and Initiated Antiretroviral Therapy;Clinical Infectious Diseases;2021-12-10